Clinical Trials Logo

Tonsillectomy clinical trials

View clinical trials related to Tonsillectomy.

Filter by:

NCT ID: NCT02934191 Completed - Tonsillectomy Clinical Trials

Celecoxib After Tonsillectomy

Start date: June 2016
Phase: Phase 2
Study type: Interventional

Tonsillectomy is one of the most common pediatric surgical procedures in the United States. Postoperative pain is substantial, with typical regimens employing narcotic derivatives and acetaminophen for 1-2 weeks after surgery. Recent enthusiasm for use of ibuprofen as an alternative has been tempered by equivocal data on its relative safety in regard to risk of postoperative hemorrhage. The primary objective is to evaluate efficacy of celecoxib for pain control after tonsillectomy in children. The secondary objective is to assess safety in regard to postoperative hemorrhage and adverse events.

NCT ID: NCT02876575 Completed - Tonsillectomy Clinical Trials

A Study of BiZact™ on Adults Undergoing Tonsillectomy

Start date: February 13, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the severity of post-operative pain following the use of the BiZact™ device in adult (≥22 years of age in United States and ≥18 years of age in Europe) tonsillectomy procedures.

NCT ID: NCT02859090 Completed - Tonsillectomy Clinical Trials

Study of the Expression of Heat Shock Proteins in Populations of B Lymphocytes in Human Tonsils

HOTLYMPHO
Start date: August 26, 2014
Phase: N/A
Study type: Interventional

It has recently been shown that various HSPs are strongly expressed in B lymphomas. Indeed, HSP90 stabilizes the protein Bcl-6 in diffuse large-cell B lymphomas. Pharmacological inhibition of HSP90 in vitro induced apoptosis in lymphoma cells (Cerchietti et al. Nat. Medicine, 2009, 1369-1376). In addition, HSP110 is strongly expressed in non-Hodgkin lymphomas, and targeting this HSP at the cell surface using specific antibodies could constitute a future therapy (Zappasodi et al. Blood, 2011, 4421-4430). Despite the importance of these proteins in the development of lymphomas, their expression and their role in the activation of normal B lymphocytes and the normal development of germinal centres is not known. The expression of Heat shock proteins should vary among the different B lymphocyte populations present in the tonsils (naïve B cells, memory B cells, germinal centre B cells). The aim of this study is to establish an expression profile for heat shock proteins in populations of B lymphocytes in human tonsils

NCT ID: NCT02517658 Completed - Tonsillectomy Clinical Trials

Adenotonsillectomy Postoperative Parental Teaching Tool

Start date: June 2015
Phase: N/A
Study type: Interventional

The study will involve parents filling out a survey before & after watching a teaching tool video (https://www.youtube.com/watch?v=rIH63jqvlio) in addition to standard post-op teaching. The parents randomized to the video arms will watch the video while their child is in the OR and then either take the post survey immediately after or wait to take the survey until just prior to discharge. Parents not in the video arms of the study will also be asked to complete a survey pre and post standard pain management teaching.

NCT ID: NCT02228135 Completed - Tonsillectomy Clinical Trials

The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage

Start date: September 2014
Phase: N/A
Study type: Observational

This is a retrospective chart review looking at the effect of dexamethasone dosing on post-tonsillectomy hemorrhage.

NCT ID: NCT02190162 Completed - Tonsillectomy Clinical Trials

The Influence of Tantum Verde® on Recovery Following Tonsillectomy

Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of Tantum Verde® for improving recovery following tonsillectomy Study design: A prospective double-blined randomized trial. Sample size: Thirty patients undergoing tonsillectomy who will be treated with Tantum Verde® Mouth wash solution, and a control group of 30 patients that will undergo tonsillectomy and will be treated with a placebo. The study will be conducted in the Departments Otolaryngology - Head and Neck Surgery in the Western Galilee Medical Center, Nahariya, Israel. Patients who are scheduled for tonsillectomy with or without adenoidectomy will be recruited for the study. They will sign the inform consent in one of two places: in the departments before the surgery or in the clinic in the visit before the surgery. The patients will be evaluated for their ability to gargle and spit water before the surgery, after which they will be assigned to either the treatment group who will get a solution of Tantum Verde or the control group who will receive saline with mint flavor, both in identicle bottles. Randomization will be done using a random number generator program. The patients will be asked to gargle and spit the solution they received three times a day for 30 seconds, for the following week after surgery.

NCT ID: NCT01917097 Completed - Tonsillectomy Clinical Trials

Bradycardia Following Intraoperative Administration of Dexmedetomidine

Start date: August 2013
Phase: N/A
Study type: Observational

This is a retrospective chart review to evaluate the postoperative course of all pediatric patients admitted to the hospital following adenotonsillectomy over the past 24 months to evaluate the incidence of bradycardia in children who received dexmedetomidine intraoperatively and identify confounding factors which may be precipitating the bradycardia or potentiating the negative chronotropic effects of dexmedetomidine.

NCT ID: NCT01605903 Completed - Tonsillectomy Clinical Trials

Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy

Start date: May 3, 2012
Phase: Phase 2
Study type: Interventional

Tonsillectomy (the surgical removal of the tonsils) is a commonly performed surgery in children. One risk of tonsillectomy is postoperative bleeding, and this can be more dangerous in children because their blood volume is lower than adults. Ibuprofen, a nonsteroidal anti-inflammatory medication (NSAID), is an effective pain medication. Recent guidelines, published by the American Academy of Otolaryngology, advocated use of ibuprofen after tonsillectomy. However, NSAIDs are associated with altered platelet function and a theoretical increased risk of bleeding after surgery. The investigators would like to explore the effect that ibuprofen has on postoperative bleeding, as well as validate previous studies demonstrating it is an effective pain medication after tonsillectomy.

NCT ID: NCT01552096 Completed - Postoperative Pain Clinical Trials

Tramadol Versus Lidocaine Infiltration for Tonsillectomy

Start date: December 2011
Phase: Phase 2
Study type: Interventional

The investigators postulate that the use of pre-incisional peritonsillar infiltration of tramadol or lidocaine reduces both the inflammatory response and postoperative analgesic consumption, without harmful effects. Therefore, the present study is designed to evaluate the effects of infiltration of tramadol or lidocaine on the postoperative acute-phase serum protein, C-reactive protein, and analgesic consumption after tonsillectomy.

NCT ID: NCT01528891 Completed - Tonsillectomy Clinical Trials

Dexmedetomidine as a Rapid Bolus in Children for Emergence Agitation

Start date: January 2012
Phase: Phase 3
Study type: Interventional

To Determine The Efficacy of a Rapid Bolus Injection of Dexmedetomidine on the Incidence of Emergence Agitation in Anesthetized Children and the Cardiovascular Profile of a Rapid Bolus Injection of Dexmedetomidine.